The Boston University Alzheimer's Disease Research Center (BU ADRC) is a National Institute on Aging Center focused on research aimed at reducing the human and economic costs of Alzheimer's disease through the advancement of knowledge.
Established in 1996, the BU ADRC is one of 33 AD Research Centers in the US funded by the National Institutes of Health to advance research on Alzheimer's disease and related dementias.
The Boston University Alzheimer’s Disease Research Center (BU ADRC) is committed to the goals.
We operationalize our mission through 7 tightly integrated cores: Administrative, Clinical (CC), Data Management and Statistics (DMS), Biomarker, Neuropathology Core (NPC), Outreach/Recruitment Engagement (ORE), Genetics and Molecular Profiling (GMP), and a Research Education Component (REC). Together all the cores are focused on cutting-edge research, proactive community engagement, training the next generation of AD/ADRD clinicians and researchers, and sharing key material, data, and expertise both among key partners and with the community at large. To support research each of our cores is directed by investigators with substantial expertise related to the core. Our Center is made up of a multidisciplinary group of professionals dedicated to research, clinical care, and education.
About the BU CTE Center
Boston University’s Chronic Traumatic Encephalopathy (CTE) Center conducts high-impact, innovative research on chronic traumatic encephalopathy and other long-term consequences of repetitive brain trauma in athletes, military personnel, and first responders. The mission of the CTE Center is to conduct state-of-the-art research on CTE, including its neuropathology and pathogenesis, clinical presentation, genetics and other risk factors, biomarkers, methods of detection during life, and methods of prevention and treatment.